Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.

Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.

Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6. Epub 2002 Oct 16.

PMID:
12451476
2.

Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.

Kadhim SA, Bowlin TL, Waud WR, Angers EG, Bibeau L, DeMuys JM, Bednarski K, Cimpoia A, Attardo G.

Cancer Res. 1997 Nov 1;57(21):4803-10.

3.

Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.

Batist G, Torres-Garcia S, Demuys JM, Greene D, Lehnert S, Rochon M, Panasci L.

Mol Pharmacol. 1989 Aug;36(2):224-30.

PMID:
2770701
4.

Interindividual variation in phase II detoxification enzymes in normal human colon mucosa.

Batist G, Mekhail-Ishak K, Hudson N, DeMuys JM.

Biochem Pharmacol. 1988 Nov 1;37(21):4241-3. No abstract available.

PMID:
2903744

Supplemental Content

Loading ...
Support Center